SectorPharmaceutical
Established Date27/06/2017
Listing Date11/06/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees109
Fiscal Year Ends31/12
Security TypeCommon stock
Office address10955 Vista Sorrento Parkway, Suite 200, San Diego, California, 92130
Business
IntroductionJanux Therapeutics, Inc., was incorporated in Delaware on June 27, 2017. The Company is an innovative biopharmaceutical company developing next-generation therapies based on the Company's proprietary Tumor-Activated T-Cell Enginator (TRACTr) platform technology to better treat cancer patients. The company's initial focus is to develop a new class of T-cell adapters (TCE), and the company's main product candidates are designed for clinically validated drug targets.
